1 Beyaert R, Beaugerie L, Assche G, Brochez L, Renauld JC, et al. (2013) Cancer risk in immune-mediated inflamatory diseases (IMID). Mol Canc 12: 98.
2 Hollinshead AC, Chuang C, Cooper EH, Catalona WJ (1977) Interrelationship of prealbumin and α-1 acid glycoprotein in cancer patient sera. Cancer 40: 2993-8.
3 Gabay C, Kushner I (1999) Acute-phase proteins and other systemicresponses to inflammation. New Engl J Med 11: 448-52.
4Samols D, Agrawal A, Kushner I (2002) Acute Phase Proteins. Elsevier Scientific, New York.
5 Hartz JA, Kuhn EM, Bentler SE, Levine PH, Londonb SE (1999) Prognostic factors for persons with idiopathic chronic fatigue. Arch Farm Med 8: 495-501.
6 Fukuda K, Straus SE, Hickie I, Sharpe MC, Dobbins JG, et al. (1994) The Chronic fatigue syndrome: A comprehensive approach to its definition and study. Annals Intern Med 121: 953-9.
7 Trigwell P, Hatcher S, Johnson M, Stanley P, House A (1995) "Abnormal" illness behaviour in chronic fatigue syndrome and multiple sclerosis. BMJ 311: 15-8.
8 McCauley L, Joos SK, Barkhuizen A, Shuell T, Tyree WA, et al. (2002) Chronic fatigue in a population-based study of Gulf war Veterans. Arch Environ Health 57: 340-8.
9 Smylie AL, Broderick G, Fernandes H, Razdan C, Barnes Y, et al. (2013) A comparson of sex-specific immune signatures in Gulf War illness and chronic fatigue syndrome. BMC Immunol 14: 29.
10 Wagner L, Cella D (2004) Fatigue and cancer: causes, prevalence and treatment approaches. Br J Cancer 91: 822-8.
11 Bomfim EO, Anatriello E, Nunnes MDR, Lopes LC, Lima RAG, et al. (2014) Functional interleukin-6 and cancer-related fatique in children and adolescents
12 George SM, Alfano CM, Neuhouser ML, Smith AW, Baumgartner RN, et al. (2014) Better postdiagnosis diet quality is associated with less cancer-related fatique in breast cancer survivors. J Cancer Surviv 8: 680-7.
13 Ardila CM, Guzmán IC (2015) Comparison of serum amyloid A protein and C-reactive protein levels as inflammatory markers in periodontitis. J Periodontal Implant Sci 45: 14-22.
14 Hitzig WH, Joller PW (1983) Developmental aspects of plasma proteins. diagnostic and clinical aspects. In: Proteins in Body Fluids, Amino Acids and Tumor Markers: Diagnostic and Clinical Aspects, Alen R.Liss, New York, 1-52.
15 Gruys E, Toussaint MJM, Niewold TA, Koopmans SJ (2005) Acute phase reaction and acute phase proteins. J Zhejiang Univ Sci 11: 1045-56.
Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson R (2005) Investigating diversity in human plasma proteins. Proc Natl Acad Sci 102: 10852-7.
16Nedelkov D, Kiernan UA, Niederkofler EE, Tubbs KA, Nelson R (2005) Investigating diversity in human plasma proteins. Proc Natl Acad Sci 102: 10852-7.
17 Chen HS, Wang YD, Zhou XL, Chang L, Wang L, et al. (2014) The cancer-related fatique in patients with advanced lung cancer and the relatioship with CRP, CORT, IL-6 levels in the serum. Psycho-Oncology 23: 213.
18 Minton O, Stone PC (2013) Identification of plasma proteins associated with cancer-related fatique syndrome (CRFS) in disease-free breast cancer patients using proteomic analysis. J Pain Symptom Manage 45: 868-74.
19 Kruse JL, Strouse TB (2015) Mood, fatique, and inflammation in cancer. Curr Psych Rep in press.
20Novak M, Vetvicka V (2009) Glucans as biological response modifiers. Endocr Metab Immune Disord Drug Targets 9: 67 -75.
21 Richter J, Svozil V, Král V, Dobiášová LR, Vaclav Vetvicka (2015) β-glucan affects mucosal immunity in children with chronic respiratory problems under physical stress: clinical trials. Ann Transl Med 3: 1-6.
22 Stier H, Ebbeskotte V, Gruenwald J (2014) Immune-modulatory effects of dietary yeast beta-1,3/1,6-D-glucan. Nutr J 13: 38.
23 Story J, Vetvicka V, Angove M (2014) β1,3-glucan anticancer efficacies and synergies: A review. Am J Immunol 10: 131-43.
24 Vetvicka V, Vetvickova J (2012) Combination of glucan, resveratrol and vitamin C demonstrates strong anti-tumor potential. Anticancer Res 32: 81-7.
25 Vetvicka V, Garcia-Mina JM, Proctor M, Yvin J-C (2015) Humic acid and glucan: Protection against liver injury induced by carbon tetrachloride. J Med Food 18: 572-7.
26 Vetvicka V, Pinatto-Botelho MF, Dos Santos AA, De Oliveira CA (2014) Evaluation of a special combination of glucan with organic selenium derivate in different murine tumor models. Anticancer Res 34: 6939-44.
27 Vetvicka V, Richter J, Svozil V, Rajnohova Dobiasova L, Kral V (2013) Placebo-driven clinical trials of yeast-derived β-(1-3) glucan in children with chronic respiratory problems. Ann Transl Med 1: 26.
28 Vetvicka V, Vancikova Z (2010) Anti-stress action of several orally-given β-glucans. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 154: 235-8.
29 Davis JM, Murphy EA, Brown AS, Carmichael MD, Ghaffar A, et al. (2004) Effects of oat β-glucan on innate immunity and infection after excercise stress. Med Sci Sports Exerc 36: 1321-7.
30 Vetvicka V, Vetvickova J (2015) β-Glucan attenuates chronic fatique syndrome in murine model. J Nat Sci 11: e112.
31 Holmes GP, Kaplan JE, Gantz NM, Komaroff AL, Schonberger LB, et al. (1988) Chronic fatigue syndrome: aworking case definition. Ann Intern Med 108: 387-9.
32 Buchwald D, Garrity D, Pascualy R, Kith P, Ashley RL, et al. (1992) Chronic fatigue syndrome. Toxicol Ind Health 8: 157-73.
33 Yang EV, Glaser R (2000) Stress-induced immunomodulation: impact on immune defenses against infectious disease. Biomed Pharmacother 54: 245-50.
34 Uhlar CM, White head AS (1999) Serum amyloid A, the major vertebrate acute -phase reactant. Eur J Biochem 265: 501-23.
35 Shenkin A (2006) Serum prealbumin: Is it a marker of nutritional status or of risk of malnutrition? Clin Chem 52: 2177-9.
36 Vetvicka V (2013) β-Glucans as Natural Biological Response Modifiers. Nova Biomedical, New York.
37 Laccetta G, Carrone A, Burratti M, Mancino P (2015) Effects of the treatment with beta-glucan in women with cervical cytologic report of atypical squamous cells of undetermined signifikance (ascus) and low-grade squamous intra-epithelial lesions (L-SIL). Minerva Ginecol 67: 113-20.